The Ruth and Raymond Perelman Center for Advanced Medicine is a specialized medical facility located at 34th Street and Civic Center Boulevard, on the former site of the Philadelphia Civic Center, on the campus of the Hospital of the University of Pennsylvania.

During the past decade, Perelman Center for Advanced Medicine conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 33 clinical trials were completed, i.e. on average, 46.5% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 21 clinical trials were completed. i.e. 61.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Perelman Center for Advanced Medicine" #1 sponsor was "University of Pennsylvania" with 17 trials, followed by "Pfizer" with 9 trials sponsored, "Gilead Sciences" with 8 trials sponsored, "Celgene" with 7 trials sponsored and "Seagen Inc." with 7 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Perelman Center for Advanced Medicine" #1 collaborator was "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Attune Medical" with 1 trials as a collaborator and "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Perelman Center for Advanced Medicine" are "Breast Cancer" (3 trials), "Eosinophilic Esophagitis" (3 trials), "HIV-1 Infection" (3 trials), "Multiple Myeloma" (3 trials) and "Nonalcoholic Steatohepatitis" (3 trials). Many other conditions were trialed in "Perelman Center for Advanced Medicine" in a lesser frequency.

Most popular intervention types in "Perelman Center for Advanced Medicine" are "Drug" (61 trials), "Other" (18 trials), "Biological" (10 trials), "Device" (6 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "SEL" (3 trials), "placebo" (3 trials), "tucatinib" (3 trials) and "B/F/TAF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Perelman Center for Advanced Medicine" are 83 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Perelman Center for Advanced Medicine". 1 are not yet recruiting, 18 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Perelman Center for Advanced Medicine, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Perelman Center for Advanced Medicine, 16 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".